Literature DB >> 11718487

Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.

C D Hatch1, B C Lund, P J Perry.   

Abstract

Neuroleptic malignant syndrome (NMS) is an uncommon but potentially life-threatening adverse effect associated with conventional antipsychotic agents. The syndrome is characterized by muscular rigidity, hyperpyrexia, altered consciousness, and autonomic dysfunction. Few cases of quetiapine-induced NMS have been reported. A 54-year-old man was unsuccessfully challenged with quetiapine after conventional antipsychotic-induced NMS.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11718487     DOI： 10.1592/phco.21.11.1003.34528

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN： 0277-0008            Impact factor:   4.705


  5 in total

1.  A Rare Case of Myxedema Coma with Neuroleptic Malignant Syndrome (NMS).

Authors:  Siddharth Dixit; Manoj Kumar Dutta; Mayank Namdeo
Journal:  J Clin Diagn Res       Date:  2015-05-01

2.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12

Review 3.  Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.

Authors:  Julian N Trollor; Xiaohua Chen; Perminder S Sachdev
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

4.  Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.

Authors:  Fan Zhang; Parisa Kanzali; Vadim Rubin; Chris Paras; Joel Goldman
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

5.  A Case of Neuroleptic Malignant Syndrome in a Profoundly Intellectually Disabled Patient with Successful Reintroduction of Antipsychotic Therapy with Quetiapine.

Authors:  Kamal Patel; Brandon Lilly; Oluwadamilare Ajayi; Kelly Melvin
Journal:  Case Rep Psychiatry       Date:  2018-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.